topical treatments for psoriasis - British Association of Dermatologists
... What are the aims of this leaflet? Patients with psoriasis are usually treated with preparations that are applied to the skin. This leaflet has been written to help you understand more about these treatments. It tells you what they are, how they are used, and where you can find out more about them. ...
... What are the aims of this leaflet? Patients with psoriasis are usually treated with preparations that are applied to the skin. This leaflet has been written to help you understand more about these treatments. It tells you what they are, how they are used, and where you can find out more about them. ...
Evidence-based treatments of addiction
... oral form of delta-9-tetrahydrocannabinol, but controlled clinical trials are lacking. (a) Detoxification by the suppression of autonomic hyperactivity For opiate detoxification, methadone is not always available due to legal limitations and buprenorphine may be undesirable because it is a partial o ...
... oral form of delta-9-tetrahydrocannabinol, but controlled clinical trials are lacking. (a) Detoxification by the suppression of autonomic hyperactivity For opiate detoxification, methadone is not always available due to legal limitations and buprenorphine may be undesirable because it is a partial o ...
New Concepts in Central Serous Chorioretinopathy
... Complications from PDT for CSC, especially when modified, are RARE. Complications rarely may include: ...
... Complications from PDT for CSC, especially when modified, are RARE. Complications rarely may include: ...
university curriculum vitae format
... or Interferon Beta 1a) to Natalizumab in Patients with Relapsing Remitting Multiple Sclerosis, 10/10-03/11, $8,078 3. Serono, A Phase III, randomized, double-blind, placebo-controlled, multi-center clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting t ...
... or Interferon Beta 1a) to Natalizumab in Patients with Relapsing Remitting Multiple Sclerosis, 10/10-03/11, $8,078 3. Serono, A Phase III, randomized, double-blind, placebo-controlled, multi-center clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting t ...
IgG4-RD
... A subset of patients with “idiopathic” retroperitoneal fibrosis (Ormond’s disease) and relate d disorders (IgG4-related retroperitoneal fibrosis, IgG4-related mesenteritis) Chronic sclerosing aortitis and periaortitis (IgG4-related aortitis or periaortitis) Riedel’s thyroiditis (IgG4-related thyroid ...
... A subset of patients with “idiopathic” retroperitoneal fibrosis (Ormond’s disease) and relate d disorders (IgG4-related retroperitoneal fibrosis, IgG4-related mesenteritis) Chronic sclerosing aortitis and periaortitis (IgG4-related aortitis or periaortitis) Riedel’s thyroiditis (IgG4-related thyroid ...
The Biomarkers
... patients received either intravenous ceftriaxone, 2 g daily for 30 days, followed by oral doxycycline, 200 mg daily for 60 days, or matching intravenous and oral placebos. Each patient had welldocumented, previously treated Lyme disease but had persistent musculoskeletal pain, neurocognitive symptom ...
... patients received either intravenous ceftriaxone, 2 g daily for 30 days, followed by oral doxycycline, 200 mg daily for 60 days, or matching intravenous and oral placebos. Each patient had welldocumented, previously treated Lyme disease but had persistent musculoskeletal pain, neurocognitive symptom ...
Neuropsychiatric Symptoms Related to Interferon Therapy
... has a history of depression, it is necessary to discuss with the patient whether IFN should be ruled out, or started only under strict monitoring. It is also important to inform the patient’s family members that psychiatric symptoms may occur, and that they have to carefully observe the patient and ...
... has a history of depression, it is necessary to discuss with the patient whether IFN should be ruled out, or started only under strict monitoring. It is also important to inform the patient’s family members that psychiatric symptoms may occur, and that they have to carefully observe the patient and ...
Vitamin E (a-tocopherol)
... free radical. Conversion back to the reduced form occurs by reaction with vitamin C (ascorbate). ...
... free radical. Conversion back to the reduced form occurs by reaction with vitamin C (ascorbate). ...
reSearch: Stiff-Person Syndrome
... The purpose of this case report is to provide an overview of SPS and a description of the specific physical therapy management strategies used during a brief inpatient rehabilitation stay for a patient with SPS, illustrating the use of the patient/client management model in the Guide to Physical The ...
... The purpose of this case report is to provide an overview of SPS and a description of the specific physical therapy management strategies used during a brief inpatient rehabilitation stay for a patient with SPS, illustrating the use of the patient/client management model in the Guide to Physical The ...
Plus information on travel, IBS, physiotherapy, berries, IBD, and more.
... underwent a colon resection the next year. Today, surgeons will sometimes remove severely diseased portions of the digestive tract, but this is only as a last alternative, usually in cases of failed medical management and/or complications. An unfortunate feature of CD is that there is a high recurre ...
... underwent a colon resection the next year. Today, surgeons will sometimes remove severely diseased portions of the digestive tract, but this is only as a last alternative, usually in cases of failed medical management and/or complications. An unfortunate feature of CD is that there is a high recurre ...
The ego is not master in its own house
... of psychological conflicts that have been repressed. Only then can the underlying factors be known and treated successfully. PSYCHOANALYTIC THERAPEUTIC RELATIONSHIP INTENSIVE, LONG-TERM THERAPY: Uncovering the unconscious is a lengthy process and understanding and treating the underlying causal fact ...
... of psychological conflicts that have been repressed. Only then can the underlying factors be known and treated successfully. PSYCHOANALYTIC THERAPEUTIC RELATIONSHIP INTENSIVE, LONG-TERM THERAPY: Uncovering the unconscious is a lengthy process and understanding and treating the underlying causal fact ...
Chronic Opioid Therapy
... the time of normal tissue healing. Chronic pain can be the result of an underlying medical disease or condition, injury, medical treatment, inflammation, or an unknown cause. ...
... the time of normal tissue healing. Chronic pain can be the result of an underlying medical disease or condition, injury, medical treatment, inflammation, or an unknown cause. ...
Allergic Rhinitis
... Medications and Illegal Drugs overuse of decongestant sprays can, over time (three to five days), cause inflammation in the nasal passages and worsen rhinitis, Rhinitis Medicamentosa Aspirin, Ibuprofen, and Naproxen Oral contraceptives, hormone replacement therapy, anti-anxiety agents, some antidepr ...
... Medications and Illegal Drugs overuse of decongestant sprays can, over time (three to five days), cause inflammation in the nasal passages and worsen rhinitis, Rhinitis Medicamentosa Aspirin, Ibuprofen, and Naproxen Oral contraceptives, hormone replacement therapy, anti-anxiety agents, some antidepr ...
Oral Medroxyprogesterone Acetate and Combination Oral
... trial (RCT) performed on patients with acute uterine bleeding presenting to the Southern California Kaiser Permanente Los Angeles and West Los Angeles Medical Centers. Approval for the study was obtained from the institutional review board, the Kaiser Permanente Southern California Regional Research ...
... trial (RCT) performed on patients with acute uterine bleeding presenting to the Southern California Kaiser Permanente Los Angeles and West Los Angeles Medical Centers. Approval for the study was obtained from the institutional review board, the Kaiser Permanente Southern California Regional Research ...
(olodaterol (as hydrochloride)) - Therapeutic Goods Administration
... airway smooth muscle and beta3-adrenoceptors predominantly expressed on adipose tissue. Beta2-agonists cause bronchodilation. Although the beta2-adrenoceptor is the predominant adrenergic receptor in the airway smooth muscle, it is also present on the surface of a variety of other cells, including l ...
... airway smooth muscle and beta3-adrenoceptors predominantly expressed on adipose tissue. Beta2-agonists cause bronchodilation. Although the beta2-adrenoceptor is the predominant adrenergic receptor in the airway smooth muscle, it is also present on the surface of a variety of other cells, including l ...
Revised: January 2015 AN: 00065/2014 SUMMARY OF PRODUCT
... The chance of hepatotoxic side effects can be diminished or delayed using an effective dose that is as low as possible. Monitoring of hepatic parameters is recommended in case of a prolonged therapy It is recommended to assess the clinical pathology of the patient 2-3 weeks after start of treatment ...
... The chance of hepatotoxic side effects can be diminished or delayed using an effective dose that is as low as possible. Monitoring of hepatic parameters is recommended in case of a prolonged therapy It is recommended to assess the clinical pathology of the patient 2-3 weeks after start of treatment ...
HIGHLIGHTS OF PRESCRIBING INFORMATION with metabolic changes that may increase
... The diagnostic evaluation of patients with this syndrome is complicated. In arriving at a diagnosis, it is important to identify cases in which the clinical presentation includes both serious medical illness (e.g., pneumonia, systemic infection, etc.) and untreated or inadequately treated extrapyram ...
... The diagnostic evaluation of patients with this syndrome is complicated. In arriving at a diagnosis, it is important to identify cases in which the clinical presentation includes both serious medical illness (e.g., pneumonia, systemic infection, etc.) and untreated or inadequately treated extrapyram ...
Belimumab (Benlysta®)
... Effect in Black/African-American Patients: Exploratory sub-group analyses of SRI response rate in patients of black race were performed. In Trial 2 and Trial 3 combined, the SRI response rate in black patients (N = 148) in groups receiving Benlysta was less than that in the group receiving placebo ( ...
... Effect in Black/African-American Patients: Exploratory sub-group analyses of SRI response rate in patients of black race were performed. In Trial 2 and Trial 3 combined, the SRI response rate in black patients (N = 148) in groups receiving Benlysta was less than that in the group receiving placebo ( ...
Friends oF CanCer researCh annual Meeting
... American Association for Cancer Research Founded in 1907, the american association for Cancer research (aaCr) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. aaCr membership includes more than 37,000 laborat ...
... American Association for Cancer Research Founded in 1907, the american association for Cancer research (aaCr) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. aaCr membership includes more than 37,000 laborat ...
What Is Physiotherapy
... Research has shown that most people gain pain relief from acupuncture. This is due to the release of endorphs into the body during the acupuncture process. Endorphs are pain inhibiting substances offering the patient an analgesic effect. The scientific proof of the release of endorphs allows acupunc ...
... Research has shown that most people gain pain relief from acupuncture. This is due to the release of endorphs into the body during the acupuncture process. Endorphs are pain inhibiting substances offering the patient an analgesic effect. The scientific proof of the release of endorphs allows acupunc ...
characteristics and risk factors
... health care utilization for diagnostic and therapeutic interventions. Prolonged TB-IRIS has not been prospectively studied to date. We aimed to determine the proportion of patients with prolonged TB-IRIS, as well as the clinical characteristics and risk factors for prolonged TB-IRIS. Methods: We poo ...
... health care utilization for diagnostic and therapeutic interventions. Prolonged TB-IRIS has not been prospectively studied to date. We aimed to determine the proportion of patients with prolonged TB-IRIS, as well as the clinical characteristics and risk factors for prolonged TB-IRIS. Methods: We poo ...
chronic non-bacterial prostatitis and thermal therapy
... the US alone. Recent epidemiological studies have shown that CP/CPPS can affect men at any age, including those in their 80s. The aetiology is unknown but proposals include infectious, autoimmune, neurologic and psychiatric causes. Men with CP/CPPS are much more likely to have had a past medical his ...
... the US alone. Recent epidemiological studies have shown that CP/CPPS can affect men at any age, including those in their 80s. The aetiology is unknown but proposals include infectious, autoimmune, neurologic and psychiatric causes. Men with CP/CPPS are much more likely to have had a past medical his ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.